Alnylam Pharmaceuticals (ALNY) P/S US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| P/S | ? | 23.8 | 27.9 | 13.1 | 13.4 | 14.0 | 9.00 | ||
| Changes by years, y/y, % | -22% | +17% | -53% | +2% | +5% | -14.3% | |||
Alnylam Pharmaceuticals. P/S
Alnylam Pharmaceuticals. P/S, changes, %
Alnylam Pharmaceuticals (ALNY) P/S US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| P/S | ? | 14.9 | 17.2 | 18.7 | 14.2 | 10.3 | 9.00 | |
| Changes by years, y/y, % | +58% | +31% | +11% | +5% | -31% | |||
| Changes by quarters, q/q, % | +11% | +15% | +9% | -24% | -28% | |||